ALBANY, N.Y., April 1, 2021 /PRNewswire/ -- Self-injection devices have become a mainstay of numerous infusion therapies for long-term management of chronic conditions, mainly by making subcutaneous ...
Diabetes patients have long relied on complex glucagon kits to treat hypoglycemia. Late last summer, Xeris Pharmaceuticals aimed to change that with the first FDA-approved prefilled syringe. Now, its ...
Insulin is a hormone that helps your body move sugar from the blood into your tissues. When you have diabetes, your body may not make or use insulin the right way, so you may need to take insulin ...
The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...
The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and pharmaceutical delivery systems. According to a FutureWise Research analysis, ...
Pharma, biotech and cosmetics market supplier Gerresheimer AG is investing about $180 million (166 million euros) to expand its facility in Peachtree City, Ga., by 53,800 square feet, to add ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback